Last reviewed · How we verify
Intracoronary injection of stem cell — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Intracoronary injection of stem cell (Intracoronary injection of stem cell) — SCARM Institute, Tabriz, Iran.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intracoronary injection of stem cell TARGET | Intracoronary injection of stem cell | SCARM Institute, Tabriz, Iran | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intracoronary injection of stem cell CI watch — RSS
- Intracoronary injection of stem cell CI watch — Atom
- Intracoronary injection of stem cell CI watch — JSON
- Intracoronary injection of stem cell alone — RSS
Cite this brief
Drug Landscape (2026). Intracoronary injection of stem cell — Competitive Intelligence Brief. https://druglandscape.com/ci/intracoronary-injection-of-stem-cell. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab